Intended for healthcare professionals

  1. Research
  2. Risk of non-fatal...
  3. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
CCBYNC Open access
Research

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2151 (Published 21 April 2011) Cite this as: BMJ 2011;342:d2151

Related articles

See more

Cited by...

  • Womens health in The BMJ: a data science history
  • Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
  • Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
  • Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
  • Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases
  • Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
  • Venous Thromboembolic Disease
  • Continuation rates of oral hormonal contraceptives in a cohort of first-time users: a population-based registry study, Sweden 2005-2010
  • Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
  • Authors' reply to Costescu and Waddington
  • Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
  • French doctors are told to restrict use of third and fourth generation oral contraceptives
  • Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
  • Long-term tolerability of ethinylestradiol 20 {micro}g/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
  • Risk of venous thromboembolism with oral contraceptives
  • Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
  • Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel
  • DTB Select: 6 | July 2011
  • Venous thromboembolism is egregiously underestimated
  • Levonorgestrel-Containing Oral Contraceptives: Still Among the Safest of the Safe
  • Two case-control studies: risk of venous thromboembolism with oral contraceptives
  • The risk of deep venous thrombosis with oral contraceptives containing drospirenone
Back to top